KIWI67 said: ↑ Gosh everyone is so sceptical these days. :( So...

KIWI67 said: ↑
Gosh everyone is so sceptical these days.
So what if the Beater showed up with a brand new account on the very day that this cartel. I mean company announced it was now a dope grower.
I am sure he/she/they never got heaps of nice check shares at .001c plus options to back this deal in a zip lock bag.
I'm sure he/she/they are now selling not into the .003c-.004c lines they manufactured.

I'm sure non of the old guard shepherds would show up here either. You know. Ones that posted on CCC (Adim under creditors) KAB (Admin) RRS or NKP. (Both sold to Chinese masters) like Maclead22

International goldfields. What a great name! Very popular it seems.
I reminder a International goldfields ICG.
Not like here.
They had directors like Mr Antony William Paul Sage, Mr Mark Gwynne and Company Secretary is Ms Jane Flegg. Not like here.

They sold a Platinum farm to NKP (Peter Landua. Okap) . $60m for 15% I believe it was. They did sell 5% for $10m to NKP in 2010 from memory. Macleod22. You should be able to help me out there. You're still posting there. Do I have that right.
Gosh. You would think that the little fact that all exploration had a court order stopping it might have affected the price, let alone let investors know this small fact. Did not seem too.

But that is all $10m with of water under the bridge now.

It was very nice for International goldfields to change their name to International petroleum IOP so Sage could reuse it though.

Range under ol' cap'en peter and flegg lent International petroleum $8m in 2013. Wasn't that nice. Of course IOP was suspended not long after that and still is. Hmmmm. Looks like share holders at RRS will never see that again.

But this is a completely different company.

Those company's find "new projects" Set the inner cycle up. Promise, promise, promise. Extend time line after time line. Raise, raise raise. Dilute until you can not dilute any more. Then change projects. Consl and name change. Those campanies have all the same Corp management company. Run out of the same office. Have the same names on the boards.

But not like this company.

So dope Ah!!!


I'm excited!!!
(In a really stoned off my face sort of way when you stumble into a 7eleven with the munchies and want some ASX junk you just know will be really bad for you. But you buy it anyway. Course your to stoned!!!!!!!)
Click to expand...
Hi kiwi67

There were remarkable claims to be frontrunners in the POT oil industry in the presentation
This article really sheds true light on the claims

"
Wildflower Enters Exclusive Distribution Agreement to Provide CBD Oil to Washington State

VANCOUVER, British Columbia, May 13, 2015: Wildflower Marijuana Inc. (CSE: SUN) (FWB:RSP) (the “Company”) has entered into a Letter of Intent to acquire the exclusive rights to market, wholesale and distribute the most advanced cannabidiol vaporizer product on the market for the State of Washington. The agreement provides for an initial payment of $100,000 which includes exclusivity, $50,000 worth of inventory and a 1.5% override on any online sales or national accounts sold into Washington State.
The product is a disposable unit filled with e-liquids blended in a pharmaceutical environment under Good Management Practices and ISO certifications. The phytocannabiniod-rich Hempstalk oil, which contains the Cannabidiol (“CBD”) in the device is non-psychoactive and provides a wide-range of benefits, allowing relaxation and added benefits without the ‘high’.
The e-liquid contains no propylene glycol or polyethylene glycol, which are used in the majority of CBD infused e-liquids on the market, and instead uses only United States Pharmacopeia grade organic vegetable glycerin and other organic, all natural ingredients. The CBD oils are produced from industrial hemp grown according to the European Union’s eco-farming certification, a standard equally as stringent as the USDA Organic Standards, and are tested at each production batch to ensure they are free of pesticides, heavy metals, and other toxins. A proprietary extraction process delivers the highest quality extracts that are free of wax or solids and a high concentration of CBDs, ensuring the most effective and efficient delivery of benefits.
CBD demand has increased exponentially, although production has not always kept up with the market changes. While CBD pills have been available for many years, the vaporization of CBD from hempstalk oil is a relatively new application. Since this product is legally imported and derived from industrial hemp it can be sold into a wide range of retail outlets, whereas the majority of CBD products in Washington State are derived from cannabis and contain higher levels of THC making it only available in retail marijuana outlets. The initial targeted retailers will be the 4600 Natural and Health Food stores, the 800 Vitamin and Supplements stores and the retail cannabis stores. With integrated technologies such as a fully programmable microprocessor and non-chromium heating elements to control the vaporization temperature, this new method of delivery will be the most advanced on the market.
President and CEO William MacLean states, “I’m proud to announce the first of our line of CBD products to launch in Washington State. CBD demand has been increasing in every market and so have the different products available to meet these demands. With over 6,000 possible retailers initially targeted, Wildflower will have an inherent advantage over competitors who can only market to cannabis retail outlets.”


Wildflower Enters the Disposable Vaporizer Market

VANCOUVER, British Columbia, May 6, 2015: Wildflower Marijuana Inc. (CSE: SUN) (FWB:RSP) (the “Company”) has signed a Letter of Intent to license the most advanced technology for the delivery of oil based derivatives in the disposable vaporizer industry. The purpose of the Licensing Agreement is to pair the highest grade cannabis extract with the most advanced technology in disposable vaporizing to meet the growing demand of health conscious cannabis consumers. Wildflower will have exclusive rights to this technology in Washington State giving the Company a clear advantage over other similar products. Cannabis vaporizing continues to gain momentum with consumers and currently demand in Washington State exceeds supply.
Pursuant to the Letter of Intent, Wildflower will be granted exclusive sales and marketing rights to the vaporization product for distribution in the State of Washington for use with cannabis e-juice. This technology addresses many deficiencies in the disposable vaporizing industry. Almost all current vaporizers are manufactured in China and are heavily dependent on labour for the soldering and assembly of internal components. This heavy dependence on labour and the material of the internal components are the main reasons for the high failure rates and unreliability of vaporizers. In addition, these vaporizers use a chromium wire as heating coils/elements which heat up to 900 °F and can cause the overheating of internal elements including the concentrated oils which could emit harmful by-products.
Wildflower’s new licensing partner has engineered a new state of the art technology that allows for automated manufacturing rather than the labour intensive processes used in China. These made in the United States vaporizers have comparable manufacturing costs with exceptional quality control compared to the Chinese made units providing a far superior product. These new vaporizers use an integrated flex circuit technology that removes 90% of the internal solder points thus eliminating these engineering weaknesses. Other benefits include the use of non-chromium heating elements to allow for Positive Temperature Control that will also assist in keeping the temperature within the desirable range increasing the battery life, efficiency and ultimately the vaporizing experience of consumers.
President and CEO William MacLean commented, “This is a major milestone for our Company. Vaporizing is one of many growing trends in the cannabis sector and the lack of a proper delivery system has been a huge issue with consumers. We will continue to develop and invest in products that enhance the consumer experience while addressing these trends. We are moving as quickly as possible to launch this new technology into Washington State. We couldn’t be more pleased to have partnered with a world class company that has addressed these issues. The rollout of this product line will be our perfect market entry point and a first step in Wildflower becoming not only a global brand but a brand that stands for the highest quality and customer experience.”


Wildflower Adds New Joint Venture Partner for US Market

Vancouver, British Columbia, April 13, 2015: Wildflower Marijuana Inc. (CSE:SUN) (the “Company”) has signed a Letter of Intent with a manufacturer of cannabis e-juice. The Joint Venture is established to develop a line of e-juice products for Wildflower. The Joint Venture partner is currently a licensed Tier 3 producer and processor in the State of Washington.
Pursuant to the Joint Venture Wildflower will grant an exclusive license to manufacture, market and sell certain products, recipes, and promotional materials under the Wildflower brand in the State of Washington. As part of the agreement, Wildflower will issue 400,000 shares and pay $85,000 to its Joint Venture partner. In consideration, Wildflower will receive a licensing fee equal to 20% of the gross sales of Wildflower branded products.
Wildflower’s new joint venture partner specializes in the manufacture of cannabis e-juice/ vaporized delivery systems market sector. E-juice is a concentrated form of cannabis juice that is consumed through vaporization. The expertise, research and development from Wildflower’s new partner will help develop a full line of e-juice products for Wildflower both in the Recreational and Medicinal market segments in Washington and other markets. As the demand for cannabis continues to grow in many emerging markets so does the demand for healthier alternative forms of consumption. Vaporizing e-juice is growing at an accelerating pace ensuring that, Wildflower will be providing a full line of products to address this trend and growing demand. In the Colorado market, the trend continues to move away from consumption of dried cannabis with 50% of products sold being ancillary products such as edibles, e-juice, infused drinks, topical products, tinctures and oils.
In Washington State, licensing requirements stipulate that all license holders and their shareholders, directors, officer and financiers must be Washington State residents. While Wildflower cannot hold any interest in any license in Washington State it can license its brand and provide consulting services. These consulting services will involve the implementation of Wildflower’s Quality Assurance Program, Standard Operating Procedures and Good Manufacturing Practices to ensure all products associated with the Wildflower brand are of the highest quality.
The Washington State government continues to work hard to create a viable legal cannabis market. Recent reports show that only 118 retail shops currently report any earnings. The state has legislated giving out 334 retail licenses this year. Retail sales have risen in excess of 100% in the past 6 months. Washington State has also revisited their taxation system and have now legislated removing any excise tax which reduces the burden placed on the producers and processors. Instead they will now have one sales tax of 37% at point of purchase.
President and CEO William MacLean states, “Much like Coca Cola has bottling companies to manufacture and distribute products all over the world, Wildflower will continue to develop strategic partnerships with companies in emerging cannabis markets. These partnerships will be integral to not only developing products and addressing trends in the sector but in positioning Wildflower to set new trends. I am excited with the progress we have made and look forward to continuing to develop the Wildflower brand and product line.”
About Wildflower Marijuana Inc.
Wildflower is a cannabis company focused on developing and designing branded products in the marijuana sector. In this regard, Wildflower works exclusively in Washington State where such activity is permitted and regulated by State law, through entities which hold licenses for such activities. Further, Wildflower is advancing two applications to grow and distribute medical marijuana under an MMPR license with Health Canada. Wildflower’s proprietary growing system is designed to maximize crop yields and consistently produce pure clean pharmaceutical grade BC cannabis for patients and cannabinoid research.
On Behalf of the Board of Directors

“William MacLean”
____________________________________
William MacLean
Director and CEO


Wildflower Enters the US Marijuana Market

VANCOUVER, British Columbia, March 25, 2015: Wildflower Marijuana Inc. (CSE: SUN) (the “Company”) announces it has entered into a Letter of Intent to form a Licensing Joint Venture (the “Joint Venture”) with a licensed marijuana producer in Washington State. The Joint Venture is being formed to develop Wildflower branded products which will then be marketed and distributed by our Joint Venture partner.
Pursuant to the Joint Venture, Wildflower will grant an exclusive license to manufacture, market and sell certain products, recipes, retail merchandise and promotional materials under the Wildflower brand in the State of Washington. As part of the agreement, Wildflower will issue 1,303,800 shares and pay $250,000 to its Joint Venture partner and contribute $1,100,000 in working capital to develop the brand. In consideration, Wildflower will receive a licensing fee equal to 20% of the gross sales of Wildflower branded products. Wildflower’s joint venture partner has been in the marijuana business since 1998 and has operated a medical dispensary since 2012. The partner has agreed to negotiate in good faith combining these operations into the Joint Venture at such time as the law permits. Washington State is currently developing new rules regulating medical dispensaries. Further, Wildflower will work closely with its Joint Venture partner to implement Wildflower’s Quality Assurance Program, Standard Operating Procedures and Good Manufacturing Practices to ensure the highest quality is produced for the Wildflower brand. As part of the transaction, Wildflower has agreed to pay a commission in accordance with regulatory guidelines.
As Wildflower’s Joint Venture partner is currently producing and selling marijuana and related products, once the transaction closes Wildflower can immediately commence sales of Wildflower branded products. Work has already begun to identify new and unique product lines.
Pursuant to the Joint Venture all production from the license will be sold under the Wildflower brand. In Washington State, licensing requirements stipulate that all license holders and their shareholders, directors, officer and financiers be Washington State residents. While Wildflower cannot have any interest in any license in Washington State it can license its brand and provide consulting services to ensure all products associated with the Wildflower brand are of the highest quality.
The Washington market has approximately 370,000 cannabis users that consume approximately 175 metric tons (175,000,000 grams) of marijuana annually according to a study by the Rand Corporation, approximately double what was predicted by the State of Washington. In comparison, the legal Canadian medicinal market has approximately 59,000 registered patients. Wildflower’s Joint Venture partner is an I-502 production and processing licensee specializing in the manufacturing of cannabis concentrates. These concentrates will provide the cornerstone to many of the Wildflower product lines such as infused edibles, drinks, oils and topical products to name a few. The production license is a Tier 2 license and is expected to produce approximately 1200 pounds of cannabis in 2015. The processing license allows Wildflower’s Joint Venture partner to make other products from cannabis and distribute to all retail outlets in Washington State. Further, the processing license allows the holder to purchase wholesale cannabis from other producers.
President and CEO William MacLean states, “After many years of hard work I am excited that we will finally get to see the Wildflower brand available on store shelves. I know consumers will embrace the Wildflower product line which will transcend many different demographics. This is the first step in realizing our goal of making Wildflower a global marijuana brand. I would like to thank the Wildflower team for their diligence and commitment to making this vision a reality. In particular, Scott Walker VP of Corporate Development, whose vast contacts and expertise within the industry has opened the door to this and many more markets for the Wildflower brand.”
About Wildflower Marijuana Inc.
Wildflower is a cannabis company focused on developing and designing branded products in the marijuana sector. In this regard, Wildflower works exclusively in Washington State where such activity is permitted and regulated by State law, through entities which hold licenses for such activities. Further, Wildflower is advancing two applications to grow and distribute medical marijuana under an MMPR license with Health Canada. Wildflower’s proprietary growing system is designed to maximize crop yields and consistently produce pure clean pharmaceutical grade BC cannabis for patients and cannabinoid research.
On Behalf of the Board of Directors

“William MacLean”
____________________________________
William MacLean
Director and CEO


Wildflower Closes Private Placement

VANCOUVER, British Columbia, March 16, 2015: Wildflower Marijuana Inc. (CSE: SUN) (the “Company”) is pleased to announce that its private placement announced on February 19, 2015 was over subscribed and the Company has closed two tranches of the private placement for a total of 4,565,000 Units at a price of $0.10 per Unit for gross proceeds of $456,500.
Each Unit consists of one common share and one share purchase warrant (“Warrant”). Each whole Warrant entitles the holder to acquire one common share of the Company at a price of $0.15 for a period of 24 months following the closing date. Once resale restrictions on the Shares having expired and upon Company’s shares trading at or above a weighted average trading price of $0.25 for 30 consecutive trading days, Wildflower may give notice that the Warrants will expire 30 days from the date of providing such notice (in writing to Warrant holders and via a news release). All securities issued pursuant to the placement will be subject to a hold period of four months and one day from the date of closing.
Proceeds from the Offering will be used for advancing Wildflower’s application for a license under Health Canada’s Marihuana for Medical Purposes Regulations, other business opportunities in the medical marijuana industry and for general working capital purposes. The Company paid finder’s fees amounting to $17,500.
William MacLean, President and CEO of Wildflower stated that “I am pleased with the level of interest expressed by our shareholders and investor’s who were following our progress. Over subscription of the private placement is a testament to what management already knows, that Wildflower is poised to become a significant player in the burgeoning marijuana market.”
About Wildflower Marijuana Inc.
Wildflower is a marijuana company advancing two applications to grow and distribute medical marijuana under an MMPR license with Health Canada. Wildflower’s proprietary growing system is designed to maximize crop yields and consistently produce pure clean pharmaceutical grade BC marijuana for patients and cannabinoid research.

Download the Investors Package Today
Email:
William MacLean, President & CEO
[email protected]
Tel: (604) 559-0420
Or visit http://www.wildflower.ca/

The Canadian Stock Exchange has not reviewed, approved or disapproved the contents of this press release.
We seek Safe Harbor.

Wildflower moves MMPR application to Parksville, B.C.

Wildflower Marijuana Inc. has moved its first MMPR application to the city of Parksville. As previously mentioned in Wildflower’s press release dated Jan 20th, 2015, the City of Parksville has provided an ideal location for a medical marijuana production facility. We were drawn to Parksville for its commitment to working towards the development of a dynamic and competitive business climate within a community that fosters economic growth and sustainability.
Wildflower had unanimous decisions from both the council for the City of Parksville and the Board of the Regional District of Nanaimo for Wildflower to construct its medicinal marijuana facility on land they jointly own. As part owner of the land, approval of the agreement was necessary by the Regional District of Nanaimo.
The application for an MMPR license on land in Parksville has already been submitted to Health Canada. With our application having already been through numerous Health Canada reviews, we are optimistic that the Parksville location will be well received by Health Canada as the re submitted application is identical in most technical aspects to the original application.
The second application in Yellowpoint is proceeding with our latest response to Health Canada being sent in this week. We are pleased with the level of attention and interaction with Health Canada to date. Wildflower will continue to build a business that can offer a positive impact on the local economy and community within the Regional District of Nanaimo.
CEO William MacLean states, “We are extremely excited to have found such a progressive City that values the economic benefits that a facility of this kind can bring to the community. I haven’t heard of any other mayor making the effort to write a letter of support to Health Canada for a prospective licensed producer. This is an amazing opportunity for Wildflower and has great potential to maximize shareholder value.”
Download the Investors Package Today
Email:

About Wildflower Marijuana Inc.
Wildflower is a cannabis company advancing two applications to grow and distribute medical marihuana under an MMPR license with Health Canada. Wildflower’s proprietary growing system is designed to maximize crop yields and consistently produce pure clean pharmaceutical grade BC cannabis for patients and cannabinoid research. Wildflower has a brand positioned to be a leader in the industry.
On Behalf of the Board of Directors

“William MacLean”
William MacLean
Director and CEO

The Canadian Stock Exchange has not reviewed, approved or disapproved the contents of this press release.
We seek Safe Harbor.


Wildflower Hires Industry Leader as VP of Corporate Development

VANCOUVER, British Columbia, February 23, 2015: Wildflower Marijuana Inc. (CSE: SUN) (the “Company”) is excited to announce it has appointed G. Scott Walker as Vice President of Corporate Development. Upon identifying the emerging cannabis industry as having great potential, Mr. Walker positioned himself at the forefront of the industry by becoming a founding member of the Canadian Medical Cannabis Industry Association (CMCIA). As a former board member of the association Mr. Walker has worked closely with licensed producers and applicants of the new Marihuana for Medical Purposes Regulations (MMPR). He is also a member of the International Cannabinoid Research Society actively participating in a number of projects working to help veterans, police and first responders deal with PTSD and opiate addiction.
Mr. Walker comes to Wildflower with extensive experience in management, finance, business development, and government relations. He has been a professional Business Consultant to his clients since 1984. He spent over 25 years in Ottawa as a lobbyist, contractor and consultant to the Canadian federal government and various Industrial sectors. He was instrumental in building the Rider Travel Group where he developed over $900 million in contracts from both the private and public sectors. As part of his role building Rider, Scott served as the Director General of Member Services at the House of Commons and subsequently VP and GM of the Federal Government Travel Service with over 600 employees and 14 offices nationwide.
Mr. Walker has also represented a number of corporate clients in the defense sector. Most notably, he represented the Australian Government and their crown owned military complex, Australian Defense Industries (ADI). He was responsible for business development in Canada, US, Europe and the Middle East. During this period he won many domestic and international contracts and set up strategic partnerships for ADI with US, Canadian and international defense sector partners.
CEO, William MacLean, states, “I am excited with the addition of Scott Walker to the Wildflower Management team. As a key figure and industry leader, Scott Walker has been approached by and consulted for many groups within the cannabis industry. This has allowed him to establish many contacts in a variety of emerging markets. He has important relationships with existing Licensed Producers and Product Developers in several legal states and currently has strategic alliances with applicants in other states in the USA. With these contacts Mr. Walker will play a key role helping Wildflower develop partnerships and relationships within these markets which will give us a strong competitive edge and the ability to expand the Wildflower brand.”
Download the Investors Package Today
Email:

About Wildflower Marijuana Inc.
Wildflower is a cannabis company advancing two applications to grow and distribute medical marihuana under an MMPR license with Health Canada. Wildflower’s proprietary growing system is designed to maximize crop yields and consistently produce pure clean pharmaceutical grade BC cannabis for patients and cannabinoid research. Wildflower has a brand positioned to be a leader in the industry.
On Behalf of the Board of Directors

“William MacLean”
William MacLean
Director and CEO

The Canadian Stock Exchange has not reviewed, approved or disapproved the contents of this press release.
We seek Safe Harbor.




Wildflower Announces Private Placement

VANCOUVER, British Columbia, February 19, 2015: Wildflower Marijuana Inc. (CSE: SUN) (the “Company”) is pleased to announce is pleased to announce a private placement of up to 4,000,000 units (“Units”) at a price of C$0.10 per Unit for aggregate gross proceeds of $400,000 (the “Offering”).
Each Unit shall consist of one common share of the Issuer and one share purchase warrant (“Warrant”). Each whole Warrant will entitle the holder to acquire one common share of the Company at a price of $0.15 for a period of 24 months following the closing date of the Offering. Once resale restrictions on the Shares having expired and upon Company’s shares trading at or above a weighted average trading price of $0.25 for 15 consecutive trading days, Wildflower may give notice that the Warrants will expire 30 days from the date of providing such notice (in writing to Warrant holders and via a news release). The proceeds will be primarily used for working capital. The financing is subject to regulatory approval. All securities issued pursuant to the placement will be subject to a hold period of four months and one day from the date of closing.
Proceeds from the Offering will be used for advancing Wildflower’s application for a license under Health Canada’s Marihuana for Medical Purposes Regulations, other business opportunities in the medical marijuana industry and for general working capital purposes. The Company may pay a finder’s fee in accordance with regulatory guidelines. The Placement is subject to regulatory approval.
Download the Investors Package Today
Email:


About Wildflower Marijuana Inc.
Wildflower is a marijuana company advancing two applications to grow and distribute medical marijuana under an MMPR license with Health Canada. Wildflower’s proprietary growing system is designed to maximize crop yields and consistently produce pure clean pharmaceutical grade BC marijuana for patients and cannabinoid research.

William MacLean, President & CEO
[email protected]
Tel: (604) 559-0420
Or visit http://www.wildflower.ca/


The Canadian Stock Exchange has not reviewed, approved or disapproved the contents of this press release.
We seek Safe Harbor.

​